Skip to main content
. 2004 Jul;48(7):2588–2594. doi: 10.1128/AAC.48.7.2588-2594.2004

TABLE 2.

Overall performance of functional reporter strains

Type Class Gene Reference compounda Maximal induction (min)
Induction factorb (fold)
RLUc
Concn (μg/ml)
Z′d
Arraye Reporter Array Reporter Basal Induced MIC Inductionf
Generic pathways Fatty acid biosynthesis fabHB Cerulenin All 200 28.3 3.7 419 1,628 8 1-64 0.36
glpDg Cerulenin All 180 12.6 2.0 74 218 8 1-8 <0
Protein biosynthesis yrzIh Clindamycin 80 360 104.1 2.5 195 610 2 0.25-8 <0
Cell wall biosynthesis ypbGi Vancomycin 40, 80 80 11.4 2.0 216 882 0.25 0.125-0.25 <0
Compound classes Quinolonesj dinBk Ciprofloxacin 80 240 14.8 15.4 1,272 16,928 0.5 0.06-4 0.43
yneAl Ciprofloxacin 80 240 19.0 16.1 218 4,487 0.5 0.125-4 0.54
yorBl Ciprofloxacin 80 200 14.1 28.1 616 18,181 0.5 0.06-4 0.51
Glycopeptides ytrA Vancomycin 10 40 42.9 3.4 228 1,550 0.25 0.125-2 0.26
ywoB Vancomycin 10 60 62.1 1.9 45 101 0.25 0.125-2 <0
Individual compounds Cycloserine ydeK Cycloserine 40 160 56.2 2.2 92 382 32 8-64 0.02
Rifampicin yvgS Rifampicin 80 80 46.2 3.7 86 322 0.125 0.008-0.125 <0
Clindamycin expZ Clindamycin All 300 76.3 5.1 116 644 2 0.25-2 0.03
a

Compound for which the highest level of upregulation was observed in expression profiling experiments. This compound was also used to determine Z′.

b

Induction factors for the reporter strains were calculated from a set of experiments designed to evaluate the reporter strains in a high-throughput mode.

c

RLU, mean relative light units, as measured in a set of experiments designed to evaluate the functionality of the reporter strains (see Results). Indicated are the values measured without compound treatment (basal) and after treatment with the reference compounds (induced) at the optimal time points and concentrations.

d

The Z′ factor is a measure of assay robustness in high-throughput applications (35).

e

Gene expression profiles were collected after 10, 40, and 80 min of compound treatment.

f

Concentration window in which significant upregulation was observed.

g

glpD was selected as a specific marker gene for triclosan, but the reporter strain was responsive to cerulenin as well.

h

Two false-negative (puromycin and actinonin) and three compounds that elicited unexpected positive responses (5-fluoruracil, nitrofurantoin, and nalidixic acid) were detected with the yrzI reporter strain.

i

One false-negative (ristocetin) and one compound that elicited an unexpected positive response (polymyxin B) were detected with the ypbG reporter strain.

j

Genes were selected as marker genes for topoisomerases, but not all strains elicited a signal with the coumarins.

k

Two compounds that elicited unexpected positive responses were detected with the dinB reporter strain, azaserine and 5 fluoruracil.

l

One compound that elicited an unexpected positive response was detected with the yneA and the yorB reporter strains, azaserine.